Football Players Health Study In Person Assessments Study
NCT ID: NCT03866564
Last Updated: 2024-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
111 participants
OBSERVATIONAL
2019-04-22
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
How the Elderly Live With Pain in Heart Failure
NCT01794728
Brain Function and Perfusion in Patients With Heart Failure
NCT01756014
ACT-HF: Attention, Cognition and Self-Management in Heart Failure
NCT01064765
Biomarker Study: Heart Failure Patients at Risk
NCT05336175
Telemedicine Technology Demonstration Project for Heart Failure
NCT02115620
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The questions the study hopes to answer are as follows: 1) Are subjective complaints among former professional football players associated with objective evidence of pathology as measured by clinically accepted diagnostic testing (Primary objective), and 2) Is exposure to professional football, as defined by variables including career duration and player field position, associated with cardiac dysfunction, neurocognitive disease, chronic pain, and sleep apnea (Secondary objective).
This protocol has been constructed with an emphasis on reducing risk and maximizing yield. The Investigators who will be performing the assessments across the Harvard Medical School Institutions have worked together to minimize potential risk exposure by carefully selecting imaging protocols that limit radiation exposure, keeping phlebotomy limited, and by conducting these assessments under the supervision of investigators with established track records for conducting safe and effective human subject research.
The study visit will occur over 2\&1/2 days. All costs of transportation, lodging, and meals will be covered by the study. All participants will have the assistance of a Study Navigator, a member of the FPHS staff who will accompany the participant. This navigator will assure that the participant gets to each assessment, helps to make decisions regarding scheduling issues or conflicts, assesses the need for additional breaks, and acts as a resource and guide for the participant throughout the study. The navigator will be in communication with key members of the research team for real time decision making (aborting or skipping an assessment).
Participants will be advised that results from these assessments are research results and are not meant for any diagnosis of disease. However, assessment results will be given to the participant if they wish to receive them. Any incidental finding that may have clinical relevance will be explained by a Study Physician and the Medical Navigation Nurse, and the participant will be assisted in obtaining follow up care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multi-Afflicted
Participants with multiple self reported afflictions will undergo comprehensive research health screenings including Echocardiography (to define cardiac dysfunction), Neuropsychological Testing (to define neurocognitive disease), Pain Catastrophizing Scale (to define chronic pain), and Nocturnal Polysomnography (to define sleep apnea).
Echocardiography
Cardiac ultrasound to measure left ventricular systolic function.
Neuropsychological Testing
Standard clinical testing designed to establish or exclude the presence of cognitive dysfunction.
Quantitative Sensory Testing
Clinically accepted quantitative assessment of chronic pain burden.
Nocturnal Polysomnography
Routine overnight sleep study to measure apnea-hypopnea index.
Un-Afflicted
Participants who report no afflictions will undergo comprehensive research health screenings including Echocardiography (to define cardiac dysfunction), Neuropsychological Testing (to define neurocognitive disease), Pain Catastrophizing Scale (to define chronic pain), and Nocturnal Polysomnography (to define sleep apnea).
Echocardiography
Cardiac ultrasound to measure left ventricular systolic function.
Neuropsychological Testing
Standard clinical testing designed to establish or exclude the presence of cognitive dysfunction.
Quantitative Sensory Testing
Clinically accepted quantitative assessment of chronic pain burden.
Nocturnal Polysomnography
Routine overnight sleep study to measure apnea-hypopnea index.
Single Afflicted
Participants with one self reported afflictions will undergo comprehensive research health screenings including Echocardiography (to define cardiac dysfunction), Neuropsychological Testing (to define neurocognitive disease), Pain Catastrophizing Scale (to define chronic pain), and Nocturnal Polysomnography (to define sleep apnea).
Echocardiography
Cardiac ultrasound to measure left ventricular systolic function.
Neuropsychological Testing
Standard clinical testing designed to establish or exclude the presence of cognitive dysfunction.
Quantitative Sensory Testing
Clinically accepted quantitative assessment of chronic pain burden.
Nocturnal Polysomnography
Routine overnight sleep study to measure apnea-hypopnea index.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Echocardiography
Cardiac ultrasound to measure left ventricular systolic function.
Neuropsychological Testing
Standard clinical testing designed to establish or exclude the presence of cognitive dysfunction.
Quantitative Sensory Testing
Clinically accepted quantitative assessment of chronic pain burden.
Nocturnal Polysomnography
Routine overnight sleep study to measure apnea-hypopnea index.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Former professional football player who played between 1960 to present.
* Prior completed the first Health and Wellness Questionnaire (Q1)
* "Healthy" subjects: ability to give informed consent and comply with study procedures.
* "Afflicted" participants: must meet criteria for at least one of the following subjective afflictions based on Q1 responses: 1) Cardiovascular Dysfunction, 2) Neurocognitive Disease, 3) Chronic Pain, and/or 4) Sleep Apnea
Exclusion Criteria
* Ferromagnetic implants or objects that cannot be removed such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants or jewelry
* Body weight \>390 lbs at screening
* Inability to complete the telephone screener
* Low T-MoCA score (\<17) and absence of an available study partner if required following MD review.
* Significant behavioral or functional disability due to cognitive impairment
24 Years
55 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Harvard Medical School (HMS and HSDM)
OTHER
Beth Israel Deaconess Medical Center
OTHER
Martinos Center for Biomedical Imaging
OTHER
Brigham and Women's Hospital
OTHER
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Meagan Murphy Wasfy
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Meagan M Wasfy, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018P001929
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.